搜尋結果
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 21 小時前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on< ...
A corner of the cancer therapy market is heating up—Here are the names investors need to know ...
CNBC· 21 小時前There's been a lot of attention lately on a corner of ...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters· 18 小時前A jury in Chicago on Thursday rejected an Illinois woman’s claim that the ...
Ozempic Slows Kidney Disease, Novo Nordisk Study Finds
The Wall Street Journal· 40 分鐘前Novo Nordisk’s Ozempic drug slows the progression of chronic kidney disease and cuts ... ...
Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users
CNBC· 3 日前Nestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing & ...
Beijing drug manufacturer aiming to develop liver fibrosis drug
China Daily· 22 小時前In addition to focusing on the development and commercialization of hydronidone for ... ...
Most Thais Back PM’s Plan to Reclassify Cannabis as Drug: Survey
Bloomberg· 5 日前Have a confidential tip for our reporters? The majority of Thais support Prime Minister ... ...
Japan companies hog the spotlight as hedge funds tout their top Asia picks
Reuters· 6 小時前Japanese stocks were in focus at a hedge fund conference this week, accounting for most of the ...
JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%
CNBC· 3 日前Structure Therapeutics is an overlooked player in the GLP-1 market, and could one ...
Most Thais Support Rescheduling Cannabis As A Drug, Survey Finds
Forbes· 4 日前The findings of a survey released by Thailand’s National Institute of Development ...